newsfilter
← Latest News
GlobeNewswire·

Xenon to Report Q3 2026 Financial Results on November 9, 2026

VANCOUVER, BC and BOSTON, MA, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and